Reduction of postischemic brain damage and memory deficits following treatment with the selective adenosine A(1) receptor agonist

Documenti analoghi

• Protection against ischemic damage by adenosine amine congener, a potent and selective adenosine A(1) receptor agonist
  di: Von Lubitz, Dag K.J.E., et al.
  Pubblicazione: (1999)
• Postischemic administration of adenosine amine congener (ADAC): analysis of recovery in gerbils
  di: Von Lubitz, Dag K. J. E., et al.
  Pubblicazione: (1996)
• Chronic administration of adenosine A(3) receptor agonist and cerebral ischemia: neuronal and glial effects
  di: Von Lubitz, Dag K.J.E., et al.
  Pubblicazione: (1999)
• Effects of chronic administration of adenosine A(1) receptor agonist and antagonist on spatial learning and memory
  di: Von Lubitz, Dag K.J.E., et al.
  Pubblicazione: (1993)
• Adenosine A(1) Receptor Agonists as Clinically Viable Agents for Treatment of Ischemic Brain Disorders
  di: Bischofberger, Norbert, et al.
  Pubblicazione: (1997)